Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00664690Phase 4Withdrawn
Phase 4, randomised, double-blind trial in postoperative pain comparing Celebrex with Placebo (2 arms). Primary endpoint: Visual Analogue Score for Pain. Status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00664690.